SPBC887.16 Antibody

What is SPBC887.16 and why is it studied in fission yeast?

SPBC887.16 is a protein found in Schizosaccharomyces pombe (fission yeast) with UniProt accession number O94299. Though its complete function remains under investigation, antibodies against this protein are valuable for studying protein expression, localization, and interactions in S. pombe cellular processes. Research using SPBC887.16 antibody contributes to our understanding of fundamental cellular mechanisms in this model organism. The antibody specifically recognizes recombinant SPBC887.16 protein from S. pombe strain 972 / ATCC 24843, allowing researchers to track this protein in various experimental contexts .

What are the key specifications of commercially available SPBC887.16 antibodies?

SPBC887.16 antibodies are typically polyclonal antibodies raised in rabbits using recombinant Schizosaccharomyces pombe SPBC887.16 protein as the immunogen. These antibodies are purified via antigen affinity chromatography to ensure specificity. They are provided in liquid form with a storage buffer containing preservatives (0.03% Proclin 300) and stabilizers (50% Glycerol in 0.01M PBS, pH 7.4). The primary validated applications include ELISA and Western Blotting for detecting the target protein . The antibody's IgG isotype offers good stability and performance across standard immunological techniques commonly used in yeast research.

What are the recommended storage conditions for maintaining SPBC887.16 antibody activity?

SPBC887.16 antibodies should be stored at either -20°C or -80°C upon receipt to maintain optimal activity. Repeated freeze-thaw cycles should be strictly avoided as they can compromise antibody integrity and performance. For researchers planning multiple experiments over time, it is recommended to prepare small aliquots of the antibody upon initial receipt to minimize freeze-thaw cycles. The antibody formulation (50% glycerol in PBS with 0.03% Proclin 300) helps maintain stability during proper storage . When actively using the antibody, short-term storage (1-2 weeks) at 4°C is generally acceptable, but long-term storage should always be at -20°C or lower for maximum shelf life.

What are the optimal Western blotting conditions for SPBC887.16 antibody detection?

For optimal Western blotting with SPBC887.16 antibody, follow this methodological approach:

• Sample preparation: Harvest S. pombe cells in mid-log phase and lyse using glass bead disruption in a buffer containing protease inhibitors.

• Protein quantification: Normalize protein concentrations (typically 20-50 µg total protein per lane).

• Gel electrophoresis: Separate proteins on 10-12% SDS-PAGE gels, as SPBC887.16 has moderate molecular weight.

• Transfer: Use PVDF membranes (preferred over nitrocellulose) with standard transfer buffers.

• Blocking: Block with 5% non-fat milk in TBST for 1 hour at room temperature.

• Primary antibody: Dilute SPBC887.16 antibody 1:500 to 1:2000 in blocking buffer; incubate overnight at 4°C.

• Washing: Perform 3-5 washes with TBST, 5-10 minutes each.

• Secondary antibody: Use anti-rabbit HRP-conjugated secondary antibody (1:5000-1:10000); incubate 1 hour at room temperature.

• Detection: Visualize using enhanced chemiluminescence.

Always include appropriate positive controls (recombinant SPBC887.16 protein) and negative controls (lysates from strains with SPBC887.16 deleted if available) .

How can I optimize ELISA protocols using SPBC887.16 antibody?

For ELISA optimization with SPBC887.16 antibody, consider this methodological framework:

• Coating: Coat microplate wells with purified recombinant SPBC887.16 protein (direct ELISA) or capture antibody (sandwich ELISA) at 1-10 µg/ml in carbonate buffer (pH 9.6) overnight at 4°C.

• Blocking: Block with 1-3% BSA in PBS for 1-2 hours at room temperature.

• Sample preparation: Prepare S. pombe lysates using gentle detergent extraction to preserve protein conformations.

• Primary antibody incubation: For direct detection, use SPBC887.16 antibody at multiple dilutions (1:500 to 1:5000) to determine optimal concentration.

• Detection: Use HRP-conjugated secondary antibody followed by TMB substrate.

• Antibody titration: Test at least five different dilutions in a preliminary experiment to establish the optimal working concentration:

Include controls to verify specificity, including wells without primary antibody and wells with unrelated proteins .

What controls are essential for validating SPBC887.16 antibody specificity?

To rigorously validate SPBC887.16 antibody specificity, implement these essential controls:

• Positive control: Use recombinant SPBC887.16 protein to confirm antibody recognizes the target.

• Negative control: Test against lysates from SPBC887.16 deletion strains (if available) to confirm absence of signal.

• Pre-immune serum control: Compare results with pre-immune serum from the same rabbit to identify non-specific binding.

• Peptide competition assay: Pre-incubate antibody with excess purified SPBC887.16 protein to demonstrate signal reduction or elimination.

• Cross-reactivity assessment: Test against closely related proteins or proteins from related yeast species.

• Method validation controls: Include technical controls specific to each method (e.g., loading controls for Western blots, isotype controls for immunohistochemistry).

These controls collectively increase confidence in experimental results and help distinguish genuine signals from artifacts or non-specific reactions, which is particularly important when working with polyclonal antibodies that may contain multiple antibody species with varying specificities .

How can I reduce background when using SPBC887.16 antibody in immunoblotting?

High background is a common challenge when working with polyclonal antibodies like SPBC887.16. Implement these methodological approaches to minimize background:

• Optimize blocking: Test different blocking agents (BSA, non-fat milk, commercial blockers) and concentrations (3-5%).

• Increase washing stringency: Use higher concentrations of Tween-20 (0.1-0.3%) in wash buffers and increase wash duration and frequency.

• Dilute antibody appropriately: Titrate the antibody to find the optimal dilution that maintains specific signal while reducing background.

• Pre-adsorption technique: To remove cross-reactive antibodies, pre-incubate diluted antibody with acetone powder prepared from non-target proteins or organisms.

• Reduce antibody incubation time: Shorten primary antibody incubation from overnight to 2-4 hours if specificity is maintained.

• Use more selective detection reagents: Consider using more specific secondary antibodies or detection systems with lower background properties.

• Membrane selection: PVDF membranes often provide lower background than nitrocellulose for yeast protein detection.

For particularly challenging samples, a signal enhancement system may be employed, but carefully evaluate whether this introduces new artifacts .

What are the likely causes and solutions for weak or absent signals when using SPBC887.16 antibody?

When facing weak or absent signals with SPBC887.16 antibody, systematically investigate these potential causes and solutions:

Always include positive controls with known reactivity to distinguish between antibody failure and methodological issues. For S. pombe work, consider using epitope-tagged versions of SPBC887.16 as additional controls if antibody detection remains problematic .

How can I determine the optimal antibody concentration for my specific experimental conditions?

To determine the optimal antibody concentration, implement this systematic titration approach:

• Preliminary range-finding: Test wide dilution range (e.g., 1:100, 1:500, 1:1000, 1:5000) using positive control samples.

• Fine-tuning: Based on initial results, narrow the range and test at smaller intervals.

• Signal-to-noise quantification: For each dilution, calculate the ratio of specific signal to background signal.

• Matrix testing: Evaluate multiple primary and secondary antibody concentration combinations to find optimal pairing.

• Assessment metrics: Consider signal intensity, background levels, reagent conservation, and reproducibility.

Optimal antibody concentration depends on multiple factors including target protein abundance, sample preparation, detection method sensitivity, and incubation conditions. For most applications with SPBC887.16 antibody, starting dilutions of 1:500-1:2000 for Western blotting and 1:200-1:1000 for ELISA are reasonable initial points, but must be optimized for each specific experimental system .

How can I effectively use SPBC887.16 antibody in co-immunoprecipitation studies?

For successful co-immunoprecipitation (Co-IP) with SPBC887.16 antibody, follow this methodological framework:

• Cell lysis optimization: Use gentle non-denaturing buffers (e.g., 20mM HEPES pH 7.4, 150mM NaCl, 0.5% NP-40 or 1% Triton X-100) supplemented with protease inhibitors to preserve protein-protein interactions.

• Pre-clearing: Pre-clear lysates with protein A/G beads to reduce non-specific binding.

• Antibody coupling: For the most consistent results, couple SPBC887.16 antibody to protein A/G beads or directly to activated beads before immunoprecipitation.

• Immunoprecipitation conditions: Optimize antibody-to-lysate ratio; typically start with 2-5 μg antibody per 500 μg total protein.

• Washing stringency: Balance between removing non-specific interactions and preserving genuine protein complexes through buffer composition and wash number.

• Elution strategies: Compare different elution methods (low pH, high pH, competitive elution with peptides, or boiling in SDS buffer) to identify optimal conditions.

• Controls: Always include IgG control, input sample, and when possible, samples from SPBC887.16 deletion strains.

For detecting transient or weak interactions, consider using crosslinking agents like DSP (dithiobis(succinimidyl propionate)) before cell lysis to stabilize protein complexes .

What approaches can be used to combine SPBC887.16 antibody detection with fluorescence microscopy?

To effectively combine SPBC887.16 antibody detection with fluorescence microscopy in S. pombe research, implement these methodological strategies:

• Sample preparation:

  • Fix cells with 4% paraformaldehyde for 15-30 minutes.

  • For better antibody accessibility, consider cell wall digestion with zymolyase or lysing enzymes.

  • Permeabilize with 0.1% Triton X-100 for 5-10 minutes.

• Immunostaining:

  • Block with 3-5% BSA in PBS for 30-60 minutes.

  • Incubate with SPBC887.16 primary antibody (1:100 to 1:500 dilution) for 2 hours at room temperature or overnight at 4°C.

  • Wash extensively with PBS + 0.1% Tween-20.

  • Detect with fluorophore-conjugated anti-rabbit secondary antibody (1:500 to 1:1000 dilution).

• Counterstaining options:

  • Nuclear DNA: DAPI (1 μg/ml)

  • Cell wall: Calcofluor white (5-10 μg/ml)

  • Actin cytoskeleton: Rhodamine-phalloidin

• Advanced applications:

  • For co-localization studies, combine with other antibodies raised in different host species.

  • For live-cell imaging, consider comparing antibody results with GFP-tagged SPBC887.16 constructs.

  • Super-resolution microscopy techniques can provide more detailed localization information beyond diffraction-limited approaches.

Always include appropriate controls, including secondary-only controls to assess background fluorescence .

How can I adapt chromatin immunoprecipitation (ChIP) protocols for SPBC887.16 antibody?

For adapting ChIP protocols to use with SPBC887.16 antibody in fission yeast research, consider these methodological modifications:

• Crosslinking optimization:

  • Test different formaldehyde concentrations (0.5-1.5%) and incubation times (5-20 minutes).

  • For protein-protein interactions, consider dual crosslinking with DSG (disuccinimidyl glutarate) before formaldehyde treatment.

• Chromatin preparation:

  • For S. pombe, optimize cell wall digestion with zymolyase (5-10 mg/ml for 30-60 minutes).

  • Sonication parameters must be carefully calibrated; aim for 200-500 bp fragments.

  • Verify sonication efficiency through agarose gel electrophoresis.

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads.

  • Typically use 2-5 μg of SPBC887.16 antibody per ChIP reaction.

  • Include input control, IgG negative control, and positive control (antibody against a known chromatin-associated protein).

• Washing and elution:

  • Implement progressively stringent washing steps to reduce background.

  • Elute chromatin complexes with SDS/NaHCO₃ buffer at 65°C.

  • Reverse crosslinks overnight at 65°C.

• Analysis options:

  • qPCR for targeted analysis of specific genomic regions.

  • ChIP-seq for genome-wide binding profile analysis.

If SPBC887.16 has weak or transient DNA interactions, consider using protein-protein crosslinkers or performing ChIP against a known interacting protein as complementary approaches .

How can I quantitatively analyze Western blot data generated using SPBC887.16 antibody?

For rigorous quantitative analysis of Western blot data using SPBC887.16 antibody, follow these methodological steps:

• Image acquisition:

  • Capture images using a digital imaging system with linear dynamic range.

  • Avoid saturation by using multiple exposure times if necessary.

  • Maintain consistent imaging settings across replicates and experiments.

• Densitometric analysis:

  • Use software like ImageJ, Image Lab, or similar programs for quantification.

  • Define lanes and bands consistently.

  • Subtract background using either local or global background correction methods.

• Normalization strategies:

  • Always normalize to appropriate loading controls (e.g., GAPDH, tubulin, or total protein stain).

  • For comparing across multiple blots, include a common reference sample on each blot.

• Statistical analysis:

  • Perform at least three biological replicates for statistical validity.

  • Apply appropriate statistical tests based on experimental design (t-test, ANOVA, etc.).

  • Calculate standard deviation or standard error for error bars.

• Data presentation:

  • Present both representative blot images and quantification graphs.

  • Clearly indicate sample identity, molecular weight markers, and experimental conditions.

  • Report fold changes relative to control conditions rather than absolute values.

For time-course experiments or comparative studies, consider using heat maps or line graphs to illustrate temporal or condition-dependent changes in SPBC887.16 expression .

How should I address contradictory results between SPBC887.16 antibody detection and other experimental approaches?

When facing contradictory results between SPBC887.16 antibody detection and other experimental approaches, implement this systematic troubleshooting methodology:

• Verification of antibody specificity:

  • Repeat specificity controls (peptide competition, knockout samples).

  • Test an alternative SPBC887.16 antibody if available.

  • Consider epitope accessibility issues that might affect detection.

• Comparative analysis of methodologies:

  • Document key differences in sample preparation between techniques.

  • Evaluate sensitivity thresholds of each method.

  • Consider that different methods may detect different protein states (native vs. denatured, modified vs. unmodified).

• Biological explanations for discrepancies:

  • Post-translational modifications affecting antibody recognition

  • Alternative splicing or protein processing

  • Context-dependent protein expression or localization

  • Protein-protein interactions masking antibody binding sites

• Resolution strategies:

  • Combine multiple detection methods (antibody + fluorescent protein tagging).

  • Use orthogonal approaches (mass spectrometry, RNA-seq).

  • Modify experimental conditions to address specific hypotheses about discrepancies.

• Validation framework:

  • Design experiments specifically to test hypotheses about the contradictions.

  • Consider whether apparent contradictions reveal novel biology rather than technical issues.

Document all troubleshooting steps thoroughly to facilitate proper interpretation of results and appropriate reporting in publications .

What are the best practices for comparing SPBC887.16 expression across different experimental conditions?

For robust comparison of SPBC887.16 expression across different experimental conditions, implement these methodological best practices:

• Experimental design considerations:

  • Include all conditions in a single experiment when possible.

  • Maintain consistent sample preparation protocols across conditions.

  • Process paired or related samples simultaneously to minimize batch effects.

• Controls and normalization:

  • Include both positive controls (known expression conditions) and negative controls.

  • Implement appropriate normalization strategies (housekeeping proteins, total protein normalization).

  • Consider using spike-in controls for absolute quantification.

• Technical rigor:

  • Perform biological triplicates at minimum, preferably with technical replicates.

  • Randomize sample processing order to prevent systematic bias.

  • Blind analysis when possible to avoid unconscious bias.

• Quantification approaches:

  • Use consistent quantification methods across all samples.

  • Apply appropriate statistical tests for the experimental design.

  • Consider the distribution of your data when selecting statistical approaches.

• Data presentation:

  • Show individual data points alongside means and error bars.

  • Use consistent scales when comparing across experiments.

  • Clearly indicate statistical significance and methods used for determination.

For complex experimental designs involving multiple variables (time, treatment, genetic background), consider multivariate statistical approaches to identify significant factors affecting SPBC887.16 expression .